Pharma & Healthcare
Global Anti-Migraine Drugs Market Research Report 2025
- Sep 18, 25
- ID: 498774
- Pages: 97
- Figures: 90
- Views: 21
Report Scope
This report aims to provide a comprehensive presentation of the global market for Anti-Migraine Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Migraine Drugs.
The Anti-Migraine Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-Migraine Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-Migraine Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Eli Lilly
Abbott
Eisai
Allergan
Endo
GlaxoSmithKline
Impax Laboratories
Pfizer
AstraZeneca
Bayer
Johnson & Johnson
Merck
Teva
Amgen
Segment by Type
Triptans
Ergots
Others
Segment by Application
Women
Men
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-Migraine Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-Migraine Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for Anti-Migraine Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Migraine Drugs.
The Anti-Migraine Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-Migraine Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-Migraine Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Eli Lilly
Abbott
Eisai
Allergan
Endo
GlaxoSmithKline
Impax Laboratories
Pfizer
AstraZeneca
Bayer
Johnson & Johnson
Merck
Teva
Amgen
Segment by Type
Triptans
Ergots
Others
Segment by Application
Women
Men
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-Migraine Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-Migraine Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Anti-Migraine Drugs Market Overview
1.1 Product Definition
1.2 Anti-Migraine Drugs by Type
1.2.1 Global Anti-Migraine Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Triptans
1.2.3 Ergots
1.2.4 Others
1.3 Anti-Migraine Drugs by Application
1.3.1 Global Anti-Migraine Drugs Market Value by Application (2024 VS 2031)
1.3.2 Women
1.3.3 Men
1.4 Global Anti-Migraine Drugs Market Size Estimates and Forecasts
1.4.1 Global Anti-Migraine Drugs Revenue 2020-2031
1.4.2 Global Anti-Migraine Drugs Sales 2020-2031
1.4.3 Global Anti-Migraine Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Anti-Migraine Drugs Market Competition by Manufacturers
2.1 Global Anti-Migraine Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Anti-Migraine Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Anti-Migraine Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Anti-Migraine Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anti-Migraine Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-Migraine Drugs, Product Type & Application
2.7 Global Key Manufacturers of Anti-Migraine Drugs, Date of Enter into This Industry
2.8 Global Anti-Migraine Drugs Market Competitive Situation and Trends
2.8.1 Global Anti-Migraine Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Anti-Migraine Drugs Players Market Share by Revenue
2.8.3 Global Anti-Migraine Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Anti-Migraine Drugs Market Scenario by Region
3.1 Global Anti-Migraine Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Anti-Migraine Drugs Sales by Region: 2020-2031
3.2.1 Global Anti-Migraine Drugs Sales by Region: 2020-2025
3.2.2 Global Anti-Migraine Drugs Sales by Region: 2026-2031
3.3 Global Anti-Migraine Drugs Revenue by Region: 2020-2031
3.3.1 Global Anti-Migraine Drugs Revenue by Region: 2020-2025
3.3.2 Global Anti-Migraine Drugs Revenue by Region: 2026-2031
3.4 North America Anti-Migraine Drugs Market Facts & Figures by Country
3.4.1 North America Anti-Migraine Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Anti-Migraine Drugs Sales by Country (2020-2031)
3.4.3 North America Anti-Migraine Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Anti-Migraine Drugs Market Facts & Figures by Country
3.5.1 Europe Anti-Migraine Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Anti-Migraine Drugs Sales by Country (2020-2031)
3.5.3 Europe Anti-Migraine Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-Migraine Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Anti-Migraine Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Anti-Migraine Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Anti-Migraine Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Anti-Migraine Drugs Market Facts & Figures by Country
3.7.1 Latin America Anti-Migraine Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Anti-Migraine Drugs Sales by Country (2020-2031)
3.7.3 Latin America Anti-Migraine Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti-Migraine Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-Migraine Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Anti-Migraine Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Anti-Migraine Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Anti-Migraine Drugs Sales by Type (2020-2031)
4.1.1 Global Anti-Migraine Drugs Sales by Type (2020-2025)
4.1.2 Global Anti-Migraine Drugs Sales by Type (2026-2031)
4.1.3 Global Anti-Migraine Drugs Sales Market Share by Type (2020-2031)
4.2 Global Anti-Migraine Drugs Revenue by Type (2020-2031)
4.2.1 Global Anti-Migraine Drugs Revenue by Type (2020-2025)
4.2.2 Global Anti-Migraine Drugs Revenue by Type (2026-2031)
4.2.3 Global Anti-Migraine Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Anti-Migraine Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Anti-Migraine Drugs Sales by Application (2020-2031)
5.1.1 Global Anti-Migraine Drugs Sales by Application (2020-2025)
5.1.2 Global Anti-Migraine Drugs Sales by Application (2026-2031)
5.1.3 Global Anti-Migraine Drugs Sales Market Share by Application (2020-2031)
5.2 Global Anti-Migraine Drugs Revenue by Application (2020-2031)
5.2.1 Global Anti-Migraine Drugs Revenue by Application (2020-2025)
5.2.2 Global Anti-Migraine Drugs Revenue by Application (2026-2031)
5.2.3 Global Anti-Migraine Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Anti-Migraine Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Eli Lilly
6.1.1 Eli Lilly Company Information
6.1.2 Eli Lilly Description and Business Overview
6.1.3 Eli Lilly Anti-Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Eli Lilly Anti-Migraine Drugs Product Portfolio
6.1.5 Eli Lilly Recent Developments/Updates
6.2 Abbott
6.2.1 Abbott Company Information
6.2.2 Abbott Description and Business Overview
6.2.3 Abbott Anti-Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Abbott Anti-Migraine Drugs Product Portfolio
6.2.5 Abbott Recent Developments/Updates
6.3 Eisai
6.3.1 Eisai Company Information
6.3.2 Eisai Description and Business Overview
6.3.3 Eisai Anti-Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Eisai Anti-Migraine Drugs Product Portfolio
6.3.5 Eisai Recent Developments/Updates
6.4 Allergan
6.4.1 Allergan Company Information
6.4.2 Allergan Description and Business Overview
6.4.3 Allergan Anti-Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Allergan Anti-Migraine Drugs Product Portfolio
6.4.5 Allergan Recent Developments/Updates
6.5 Endo
6.5.1 Endo Company Information
6.5.2 Endo Description and Business Overview
6.5.3 Endo Anti-Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Endo Anti-Migraine Drugs Product Portfolio
6.5.5 Endo Recent Developments/Updates
6.6 GlaxoSmithKline
6.6.1 GlaxoSmithKline Company Information
6.6.2 GlaxoSmithKline Description and Business Overview
6.6.3 GlaxoSmithKline Anti-Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 GlaxoSmithKline Anti-Migraine Drugs Product Portfolio
6.6.5 GlaxoSmithKline Recent Developments/Updates
6.7 Impax Laboratories
6.7.1 Impax Laboratories Company Information
6.7.2 Impax Laboratories Description and Business Overview
6.7.3 Impax Laboratories Anti-Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Impax Laboratories Anti-Migraine Drugs Product Portfolio
6.7.5 Impax Laboratories Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Company Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Anti-Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Pfizer Anti-Migraine Drugs Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 AstraZeneca
6.9.1 AstraZeneca Company Information
6.9.2 AstraZeneca Description and Business Overview
6.9.3 AstraZeneca Anti-Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 AstraZeneca Anti-Migraine Drugs Product Portfolio
6.9.5 AstraZeneca Recent Developments/Updates
6.10 Bayer
6.10.1 Bayer Company Information
6.10.2 Bayer Description and Business Overview
6.10.3 Bayer Anti-Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Bayer Anti-Migraine Drugs Product Portfolio
6.10.5 Bayer Recent Developments/Updates
6.11 Johnson & Johnson
6.11.1 Johnson & Johnson Company Information
6.11.2 Johnson & Johnson Description and Business Overview
6.11.3 Johnson & Johnson Anti-Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Johnson & Johnson Anti-Migraine Drugs Product Portfolio
6.11.5 Johnson & Johnson Recent Developments/Updates
6.12 Merck
6.12.1 Merck Company Information
6.12.2 Merck Description and Business Overview
6.12.3 Merck Anti-Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Merck Anti-Migraine Drugs Product Portfolio
6.12.5 Merck Recent Developments/Updates
6.13 Teva
6.13.1 Teva Company Information
6.13.2 Teva Description and Business Overview
6.13.3 Teva Anti-Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Teva Anti-Migraine Drugs Product Portfolio
6.13.5 Teva Recent Developments/Updates
6.14 Amgen
6.14.1 Amgen Company Information
6.14.2 Amgen Description and Business Overview
6.14.3 Amgen Anti-Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Amgen Anti-Migraine Drugs Product Portfolio
6.14.5 Amgen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-Migraine Drugs Industry Chain Analysis
7.2 Anti-Migraine Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-Migraine Drugs Production Mode & Process Analysis
7.4 Anti-Migraine Drugs Sales and Marketing
7.4.1 Anti-Migraine Drugs Sales Channels
7.4.2 Anti-Migraine Drugs Distributors
7.5 Anti-Migraine Drugs Customer Analysis
8 Anti-Migraine Drugs Market Dynamics
8.1 Anti-Migraine Drugs Industry Trends
8.2 Anti-Migraine Drugs Market Drivers
8.3 Anti-Migraine Drugs Market Challenges
8.4 Anti-Migraine Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Anti-Migraine Drugs by Type
1.2.1 Global Anti-Migraine Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Triptans
1.2.3 Ergots
1.2.4 Others
1.3 Anti-Migraine Drugs by Application
1.3.1 Global Anti-Migraine Drugs Market Value by Application (2024 VS 2031)
1.3.2 Women
1.3.3 Men
1.4 Global Anti-Migraine Drugs Market Size Estimates and Forecasts
1.4.1 Global Anti-Migraine Drugs Revenue 2020-2031
1.4.2 Global Anti-Migraine Drugs Sales 2020-2031
1.4.3 Global Anti-Migraine Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Anti-Migraine Drugs Market Competition by Manufacturers
2.1 Global Anti-Migraine Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Anti-Migraine Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Anti-Migraine Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Anti-Migraine Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anti-Migraine Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-Migraine Drugs, Product Type & Application
2.7 Global Key Manufacturers of Anti-Migraine Drugs, Date of Enter into This Industry
2.8 Global Anti-Migraine Drugs Market Competitive Situation and Trends
2.8.1 Global Anti-Migraine Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Anti-Migraine Drugs Players Market Share by Revenue
2.8.3 Global Anti-Migraine Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Anti-Migraine Drugs Market Scenario by Region
3.1 Global Anti-Migraine Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Anti-Migraine Drugs Sales by Region: 2020-2031
3.2.1 Global Anti-Migraine Drugs Sales by Region: 2020-2025
3.2.2 Global Anti-Migraine Drugs Sales by Region: 2026-2031
3.3 Global Anti-Migraine Drugs Revenue by Region: 2020-2031
3.3.1 Global Anti-Migraine Drugs Revenue by Region: 2020-2025
3.3.2 Global Anti-Migraine Drugs Revenue by Region: 2026-2031
3.4 North America Anti-Migraine Drugs Market Facts & Figures by Country
3.4.1 North America Anti-Migraine Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Anti-Migraine Drugs Sales by Country (2020-2031)
3.4.3 North America Anti-Migraine Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Anti-Migraine Drugs Market Facts & Figures by Country
3.5.1 Europe Anti-Migraine Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Anti-Migraine Drugs Sales by Country (2020-2031)
3.5.3 Europe Anti-Migraine Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-Migraine Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Anti-Migraine Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Anti-Migraine Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Anti-Migraine Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Anti-Migraine Drugs Market Facts & Figures by Country
3.7.1 Latin America Anti-Migraine Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Anti-Migraine Drugs Sales by Country (2020-2031)
3.7.3 Latin America Anti-Migraine Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti-Migraine Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-Migraine Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Anti-Migraine Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Anti-Migraine Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Anti-Migraine Drugs Sales by Type (2020-2031)
4.1.1 Global Anti-Migraine Drugs Sales by Type (2020-2025)
4.1.2 Global Anti-Migraine Drugs Sales by Type (2026-2031)
4.1.3 Global Anti-Migraine Drugs Sales Market Share by Type (2020-2031)
4.2 Global Anti-Migraine Drugs Revenue by Type (2020-2031)
4.2.1 Global Anti-Migraine Drugs Revenue by Type (2020-2025)
4.2.2 Global Anti-Migraine Drugs Revenue by Type (2026-2031)
4.2.3 Global Anti-Migraine Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Anti-Migraine Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Anti-Migraine Drugs Sales by Application (2020-2031)
5.1.1 Global Anti-Migraine Drugs Sales by Application (2020-2025)
5.1.2 Global Anti-Migraine Drugs Sales by Application (2026-2031)
5.1.3 Global Anti-Migraine Drugs Sales Market Share by Application (2020-2031)
5.2 Global Anti-Migraine Drugs Revenue by Application (2020-2031)
5.2.1 Global Anti-Migraine Drugs Revenue by Application (2020-2025)
5.2.2 Global Anti-Migraine Drugs Revenue by Application (2026-2031)
5.2.3 Global Anti-Migraine Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Anti-Migraine Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Eli Lilly
6.1.1 Eli Lilly Company Information
6.1.2 Eli Lilly Description and Business Overview
6.1.3 Eli Lilly Anti-Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Eli Lilly Anti-Migraine Drugs Product Portfolio
6.1.5 Eli Lilly Recent Developments/Updates
6.2 Abbott
6.2.1 Abbott Company Information
6.2.2 Abbott Description and Business Overview
6.2.3 Abbott Anti-Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Abbott Anti-Migraine Drugs Product Portfolio
6.2.5 Abbott Recent Developments/Updates
6.3 Eisai
6.3.1 Eisai Company Information
6.3.2 Eisai Description and Business Overview
6.3.3 Eisai Anti-Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Eisai Anti-Migraine Drugs Product Portfolio
6.3.5 Eisai Recent Developments/Updates
6.4 Allergan
6.4.1 Allergan Company Information
6.4.2 Allergan Description and Business Overview
6.4.3 Allergan Anti-Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Allergan Anti-Migraine Drugs Product Portfolio
6.4.5 Allergan Recent Developments/Updates
6.5 Endo
6.5.1 Endo Company Information
6.5.2 Endo Description and Business Overview
6.5.3 Endo Anti-Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Endo Anti-Migraine Drugs Product Portfolio
6.5.5 Endo Recent Developments/Updates
6.6 GlaxoSmithKline
6.6.1 GlaxoSmithKline Company Information
6.6.2 GlaxoSmithKline Description and Business Overview
6.6.3 GlaxoSmithKline Anti-Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 GlaxoSmithKline Anti-Migraine Drugs Product Portfolio
6.6.5 GlaxoSmithKline Recent Developments/Updates
6.7 Impax Laboratories
6.7.1 Impax Laboratories Company Information
6.7.2 Impax Laboratories Description and Business Overview
6.7.3 Impax Laboratories Anti-Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Impax Laboratories Anti-Migraine Drugs Product Portfolio
6.7.5 Impax Laboratories Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Company Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Anti-Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Pfizer Anti-Migraine Drugs Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 AstraZeneca
6.9.1 AstraZeneca Company Information
6.9.2 AstraZeneca Description and Business Overview
6.9.3 AstraZeneca Anti-Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 AstraZeneca Anti-Migraine Drugs Product Portfolio
6.9.5 AstraZeneca Recent Developments/Updates
6.10 Bayer
6.10.1 Bayer Company Information
6.10.2 Bayer Description and Business Overview
6.10.3 Bayer Anti-Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Bayer Anti-Migraine Drugs Product Portfolio
6.10.5 Bayer Recent Developments/Updates
6.11 Johnson & Johnson
6.11.1 Johnson & Johnson Company Information
6.11.2 Johnson & Johnson Description and Business Overview
6.11.3 Johnson & Johnson Anti-Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Johnson & Johnson Anti-Migraine Drugs Product Portfolio
6.11.5 Johnson & Johnson Recent Developments/Updates
6.12 Merck
6.12.1 Merck Company Information
6.12.2 Merck Description and Business Overview
6.12.3 Merck Anti-Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Merck Anti-Migraine Drugs Product Portfolio
6.12.5 Merck Recent Developments/Updates
6.13 Teva
6.13.1 Teva Company Information
6.13.2 Teva Description and Business Overview
6.13.3 Teva Anti-Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Teva Anti-Migraine Drugs Product Portfolio
6.13.5 Teva Recent Developments/Updates
6.14 Amgen
6.14.1 Amgen Company Information
6.14.2 Amgen Description and Business Overview
6.14.3 Amgen Anti-Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Amgen Anti-Migraine Drugs Product Portfolio
6.14.5 Amgen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-Migraine Drugs Industry Chain Analysis
7.2 Anti-Migraine Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-Migraine Drugs Production Mode & Process Analysis
7.4 Anti-Migraine Drugs Sales and Marketing
7.4.1 Anti-Migraine Drugs Sales Channels
7.4.2 Anti-Migraine Drugs Distributors
7.5 Anti-Migraine Drugs Customer Analysis
8 Anti-Migraine Drugs Market Dynamics
8.1 Anti-Migraine Drugs Industry Trends
8.2 Anti-Migraine Drugs Market Drivers
8.3 Anti-Migraine Drugs Market Challenges
8.4 Anti-Migraine Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Anti-Migraine Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Anti-Migraine Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Anti-Migraine Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Anti-Migraine Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Anti-Migraine Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Anti-Migraine Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Anti-Migraine Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Anti-Migraine Drugs Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Anti-Migraine Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Anti-Migraine Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti-Migraine Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Anti-Migraine Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-Migraine Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Migraine Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-Migraine Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Anti-Migraine Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global Anti-Migraine Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Anti-Migraine Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global Anti-Migraine Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Anti-Migraine Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Anti-Migraine Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Anti-Migraine Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Anti-Migraine Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Anti-Migraine Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Anti-Migraine Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America Anti-Migraine Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America Anti-Migraine Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Anti-Migraine Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Anti-Migraine Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Anti-Migraine Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe Anti-Migraine Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe Anti-Migraine Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Anti-Migraine Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Anti-Migraine Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Anti-Migraine Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Anti-Migraine Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Anti-Migraine Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Anti-Migraine Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Anti-Migraine Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Anti-Migraine Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Anti-Migraine Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Anti-Migraine Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Anti-Migraine Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Anti-Migraine Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Anti-Migraine Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Anti-Migraine Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Anti-Migraine Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Anti-Migraine Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Anti-Migraine Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global Anti-Migraine Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global Anti-Migraine Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Anti-Migraine Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Anti-Migraine Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Anti-Migraine Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Anti-Migraine Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Anti-Migraine Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Anti-Migraine Drugs Price (USD/Pcs) by Type (2020-2025)
Table 59. Global Anti-Migraine Drugs Price (USD/Pcs) by Type (2026-2031)
Table 60. Global Anti-Migraine Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global Anti-Migraine Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global Anti-Migraine Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Anti-Migraine Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Anti-Migraine Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Anti-Migraine Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Anti-Migraine Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Anti-Migraine Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Anti-Migraine Drugs Price (USD/Pcs) by Application (2020-2025)
Table 69. Global Anti-Migraine Drugs Price (USD/Pcs) by Application (2026-2031)
Table 70. Eli Lilly Company Information
Table 71. Eli Lilly Description and Business Overview
Table 72. Eli Lilly Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 73. Eli Lilly Anti-Migraine Drugs Product
Table 74. Eli Lilly Recent Developments/Updates
Table 75. Abbott Company Information
Table 76. Abbott Description and Business Overview
Table 77. Abbott Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Abbott Anti-Migraine Drugs Product
Table 79. Abbott Recent Developments/Updates
Table 80. Eisai Company Information
Table 81. Eisai Description and Business Overview
Table 82. Eisai Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Eisai Anti-Migraine Drugs Product
Table 84. Eisai Recent Developments/Updates
Table 85. Allergan Company Information
Table 86. Allergan Description and Business Overview
Table 87. Allergan Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Allergan Anti-Migraine Drugs Product
Table 89. Allergan Recent Developments/Updates
Table 90. Endo Company Information
Table 91. Endo Description and Business Overview
Table 92. Endo Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. Endo Anti-Migraine Drugs Product
Table 94. Endo Recent Developments/Updates
Table 95. GlaxoSmithKline Company Information
Table 96. GlaxoSmithKline Description and Business Overview
Table 97. GlaxoSmithKline Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. GlaxoSmithKline Anti-Migraine Drugs Product
Table 99. GlaxoSmithKline Recent Developments/Updates
Table 100. Impax Laboratories Company Information
Table 101. Impax Laboratories Description and Business Overview
Table 102. Impax Laboratories Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. Impax Laboratories Anti-Migraine Drugs Product
Table 104. Impax Laboratories Recent Developments/Updates
Table 105. Pfizer Company Information
Table 106. Pfizer Description and Business Overview
Table 107. Pfizer Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. Pfizer Anti-Migraine Drugs Product
Table 109. Pfizer Recent Developments/Updates
Table 110. AstraZeneca Company Information
Table 111. AstraZeneca Description and Business Overview
Table 112. AstraZeneca Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. AstraZeneca Anti-Migraine Drugs Product
Table 114. AstraZeneca Recent Developments/Updates
Table 115. Bayer Company Information
Table 116. Bayer Description and Business Overview
Table 117. Bayer Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 118. Bayer Anti-Migraine Drugs Product
Table 119. Bayer Recent Developments/Updates
Table 120. Johnson & Johnson Company Information
Table 121. Johnson & Johnson Description and Business Overview
Table 122. Johnson & Johnson Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 123. Johnson & Johnson Anti-Migraine Drugs Product
Table 124. Johnson & Johnson Recent Developments/Updates
Table 125. Merck Company Information
Table 126. Merck Description and Business Overview
Table 127. Merck Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 128. Merck Anti-Migraine Drugs Product
Table 129. Merck Recent Developments/Updates
Table 130. Teva Company Information
Table 131. Teva Description and Business Overview
Table 132. Teva Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 133. Teva Anti-Migraine Drugs Product
Table 134. Teva Recent Developments/Updates
Table 135. Amgen Company Information
Table 136. Amgen Description and Business Overview
Table 137. Amgen Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 138. Amgen Anti-Migraine Drugs Product
Table 139. Amgen Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Anti-Migraine Drugs Distributors List
Table 143. Anti-Migraine Drugs Customers List
Table 144. Anti-Migraine Drugs Market Trends
Table 145. Anti-Migraine Drugs Market Drivers
Table 146. Anti-Migraine Drugs Market Challenges
Table 147. Anti-Migraine Drugs Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Anti-Migraine Drugs
Figure 2. Global Anti-Migraine Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Anti-Migraine Drugs Market Share by Type: 2024 & 2031
Figure 4. Triptans Product Picture
Figure 5. Ergots Product Picture
Figure 6. Others Product Picture
Figure 7. Global Anti-Migraine Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Anti-Migraine Drugs Market Share by Application: 2024 & 2031
Figure 9. Women
Figure 10. Men
Figure 11. Global Anti-Migraine Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Anti-Migraine Drugs Market Size (2020-2031) & (US$ Million)
Figure 13. Global Anti-Migraine Drugs Sales (2020-2031) & (K Units)
Figure 14. Global Anti-Migraine Drugs Average Price (USD/Pcs) & (2020-2031)
Figure 15. Anti-Migraine Drugs Report Years Considered
Figure 16. Anti-Migraine Drugs Sales Share by Manufacturers in 2024
Figure 17. Global Anti-Migraine Drugs Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Anti-Migraine Drugs Players: Market Share by Revenue in Anti-Migraine Drugs in 2024
Figure 19. Anti-Migraine Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Anti-Migraine Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Anti-Migraine Drugs Sales Market Share by Country (2020-2031)
Figure 22. North America Anti-Migraine Drugs Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Anti-Migraine Drugs Sales Market Share by Country (2020-2031)
Figure 26. Europe Anti-Migraine Drugs Revenue Market Share by Country (2020-2031)
Figure 27. Germany Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Anti-Migraine Drugs Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Anti-Migraine Drugs Revenue Market Share by Region (2020-2031)
Figure 34. China Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Taiwan Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Philippines Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Anti-Migraine Drugs Sales Market Share by Country (2020-2031)
Figure 45. Latin America Anti-Migraine Drugs Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Anti-Migraine Drugs Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Anti-Migraine Drugs Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. U.A.E Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Anti-Migraine Drugs by Type (2020-2031)
Figure 55. Global Revenue Market Share of Anti-Migraine Drugs by Type (2020-2031)
Figure 56. Global Anti-Migraine Drugs Price (USD/Pcs) by Type (2020-2031)
Figure 57. Global Sales Market Share of Anti-Migraine Drugs by Application (2020-2031)
Figure 58. Global Revenue Market Share of Anti-Migraine Drugs by Application (2020-2031)
Figure 59. Global Anti-Migraine Drugs Price (USD/Pcs) by Application (2020-2031)
Figure 60. Anti-Migraine Drugs Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Anti-Migraine Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Anti-Migraine Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Anti-Migraine Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Anti-Migraine Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Anti-Migraine Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Anti-Migraine Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Anti-Migraine Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Anti-Migraine Drugs Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Anti-Migraine Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Anti-Migraine Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti-Migraine Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Anti-Migraine Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-Migraine Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Migraine Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-Migraine Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Anti-Migraine Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global Anti-Migraine Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Anti-Migraine Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global Anti-Migraine Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Anti-Migraine Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Anti-Migraine Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Anti-Migraine Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Anti-Migraine Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Anti-Migraine Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Anti-Migraine Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America Anti-Migraine Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America Anti-Migraine Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Anti-Migraine Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Anti-Migraine Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Anti-Migraine Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe Anti-Migraine Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe Anti-Migraine Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Anti-Migraine Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Anti-Migraine Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Anti-Migraine Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Anti-Migraine Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Anti-Migraine Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Anti-Migraine Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Anti-Migraine Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Anti-Migraine Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Anti-Migraine Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Anti-Migraine Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Anti-Migraine Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Anti-Migraine Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Anti-Migraine Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Anti-Migraine Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Anti-Migraine Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Anti-Migraine Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Anti-Migraine Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global Anti-Migraine Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global Anti-Migraine Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Anti-Migraine Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Anti-Migraine Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Anti-Migraine Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Anti-Migraine Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Anti-Migraine Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Anti-Migraine Drugs Price (USD/Pcs) by Type (2020-2025)
Table 59. Global Anti-Migraine Drugs Price (USD/Pcs) by Type (2026-2031)
Table 60. Global Anti-Migraine Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global Anti-Migraine Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global Anti-Migraine Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Anti-Migraine Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Anti-Migraine Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Anti-Migraine Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Anti-Migraine Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Anti-Migraine Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Anti-Migraine Drugs Price (USD/Pcs) by Application (2020-2025)
Table 69. Global Anti-Migraine Drugs Price (USD/Pcs) by Application (2026-2031)
Table 70. Eli Lilly Company Information
Table 71. Eli Lilly Description and Business Overview
Table 72. Eli Lilly Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 73. Eli Lilly Anti-Migraine Drugs Product
Table 74. Eli Lilly Recent Developments/Updates
Table 75. Abbott Company Information
Table 76. Abbott Description and Business Overview
Table 77. Abbott Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Abbott Anti-Migraine Drugs Product
Table 79. Abbott Recent Developments/Updates
Table 80. Eisai Company Information
Table 81. Eisai Description and Business Overview
Table 82. Eisai Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Eisai Anti-Migraine Drugs Product
Table 84. Eisai Recent Developments/Updates
Table 85. Allergan Company Information
Table 86. Allergan Description and Business Overview
Table 87. Allergan Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Allergan Anti-Migraine Drugs Product
Table 89. Allergan Recent Developments/Updates
Table 90. Endo Company Information
Table 91. Endo Description and Business Overview
Table 92. Endo Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. Endo Anti-Migraine Drugs Product
Table 94. Endo Recent Developments/Updates
Table 95. GlaxoSmithKline Company Information
Table 96. GlaxoSmithKline Description and Business Overview
Table 97. GlaxoSmithKline Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. GlaxoSmithKline Anti-Migraine Drugs Product
Table 99. GlaxoSmithKline Recent Developments/Updates
Table 100. Impax Laboratories Company Information
Table 101. Impax Laboratories Description and Business Overview
Table 102. Impax Laboratories Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. Impax Laboratories Anti-Migraine Drugs Product
Table 104. Impax Laboratories Recent Developments/Updates
Table 105. Pfizer Company Information
Table 106. Pfizer Description and Business Overview
Table 107. Pfizer Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. Pfizer Anti-Migraine Drugs Product
Table 109. Pfizer Recent Developments/Updates
Table 110. AstraZeneca Company Information
Table 111. AstraZeneca Description and Business Overview
Table 112. AstraZeneca Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. AstraZeneca Anti-Migraine Drugs Product
Table 114. AstraZeneca Recent Developments/Updates
Table 115. Bayer Company Information
Table 116. Bayer Description and Business Overview
Table 117. Bayer Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 118. Bayer Anti-Migraine Drugs Product
Table 119. Bayer Recent Developments/Updates
Table 120. Johnson & Johnson Company Information
Table 121. Johnson & Johnson Description and Business Overview
Table 122. Johnson & Johnson Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 123. Johnson & Johnson Anti-Migraine Drugs Product
Table 124. Johnson & Johnson Recent Developments/Updates
Table 125. Merck Company Information
Table 126. Merck Description and Business Overview
Table 127. Merck Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 128. Merck Anti-Migraine Drugs Product
Table 129. Merck Recent Developments/Updates
Table 130. Teva Company Information
Table 131. Teva Description and Business Overview
Table 132. Teva Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 133. Teva Anti-Migraine Drugs Product
Table 134. Teva Recent Developments/Updates
Table 135. Amgen Company Information
Table 136. Amgen Description and Business Overview
Table 137. Amgen Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 138. Amgen Anti-Migraine Drugs Product
Table 139. Amgen Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Anti-Migraine Drugs Distributors List
Table 143. Anti-Migraine Drugs Customers List
Table 144. Anti-Migraine Drugs Market Trends
Table 145. Anti-Migraine Drugs Market Drivers
Table 146. Anti-Migraine Drugs Market Challenges
Table 147. Anti-Migraine Drugs Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Anti-Migraine Drugs
Figure 2. Global Anti-Migraine Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Anti-Migraine Drugs Market Share by Type: 2024 & 2031
Figure 4. Triptans Product Picture
Figure 5. Ergots Product Picture
Figure 6. Others Product Picture
Figure 7. Global Anti-Migraine Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Anti-Migraine Drugs Market Share by Application: 2024 & 2031
Figure 9. Women
Figure 10. Men
Figure 11. Global Anti-Migraine Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Anti-Migraine Drugs Market Size (2020-2031) & (US$ Million)
Figure 13. Global Anti-Migraine Drugs Sales (2020-2031) & (K Units)
Figure 14. Global Anti-Migraine Drugs Average Price (USD/Pcs) & (2020-2031)
Figure 15. Anti-Migraine Drugs Report Years Considered
Figure 16. Anti-Migraine Drugs Sales Share by Manufacturers in 2024
Figure 17. Global Anti-Migraine Drugs Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Anti-Migraine Drugs Players: Market Share by Revenue in Anti-Migraine Drugs in 2024
Figure 19. Anti-Migraine Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Anti-Migraine Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Anti-Migraine Drugs Sales Market Share by Country (2020-2031)
Figure 22. North America Anti-Migraine Drugs Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Anti-Migraine Drugs Sales Market Share by Country (2020-2031)
Figure 26. Europe Anti-Migraine Drugs Revenue Market Share by Country (2020-2031)
Figure 27. Germany Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Anti-Migraine Drugs Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Anti-Migraine Drugs Revenue Market Share by Region (2020-2031)
Figure 34. China Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Taiwan Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Philippines Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Anti-Migraine Drugs Sales Market Share by Country (2020-2031)
Figure 45. Latin America Anti-Migraine Drugs Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Anti-Migraine Drugs Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Anti-Migraine Drugs Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. U.A.E Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Anti-Migraine Drugs by Type (2020-2031)
Figure 55. Global Revenue Market Share of Anti-Migraine Drugs by Type (2020-2031)
Figure 56. Global Anti-Migraine Drugs Price (USD/Pcs) by Type (2020-2031)
Figure 57. Global Sales Market Share of Anti-Migraine Drugs by Application (2020-2031)
Figure 58. Global Revenue Market Share of Anti-Migraine Drugs by Application (2020-2031)
Figure 59. Global Anti-Migraine Drugs Price (USD/Pcs) by Application (2020-2031)
Figure 60. Anti-Migraine Drugs Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Ethylene Oxide (EO) Market Research Report 2026
Jan 17, 26
Global Stem Cells Cryopreservation Equipments Market Research Report 2026
Jan 17, 26
Global Selenium-enriched Yeast Market Research Report 2026
Jan 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232